✦ LIBER ✦
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients
✍ Scribed by Richard J. Benjamin; Jeffrey McCullough; Paul D. Mintz; Edward Snyder; William D. Spotnitz; Robert J. Rizzo; David Wages; Jin-Sying Lin; Lindsey Wood; Laurence Corash; Maureen G. Conlan
- Book ID
- 109142873
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 109 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0372-1248
No coin nor oath required. For personal study only.